FDA recall D-0148-2021

Biogen MA Inc. · Class II · drug

Product

Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in a) 106-count bottle, b)120-count bottle, Rx only, Manufactured for: Biogen Inc., Cambridge, MA 02142, NDC 64406-020-01

Reason for recall

Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing.

Distribution

USA Nationwide

Key facts

Status
Terminated
Initiation date
2020-12-09
Report date
2020-12-23
Termination date
2021-09-17
Voluntary/Mandated
Voluntary: Firm initiated
Location
Research Triangle Park, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0148-2021